title: Metolazone-induced cholestatic liver disease.
authors.forename: M
authors.initials: M
authors.lastname: Gabrielli
authors.forename: A
authors.initials: A
authors.lastname: Gasbarrini
authors.forename: A
authors.initials: A
authors.lastname: Santoliquido
authors.forename: R
authors.initials: R
authors.lastname: Flore
authors.forename: E
authors.initials: E
authors.lastname: Gaetani
authors.forename: A
authors.initials: A
authors.lastname: Flex
authors.forename: P
authors.initials: P
authors.lastname: Pola
mesh_terms: D000328:Adult; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy; D002779:Cholestasis / Q000139:chemically induced*; D004232:Diuretics / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008788:Metolazone / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D004232:Diuretics; D008788:Metolazone